Founders & Innovation Team
Nance Dicciani
Co-Founder, CEO
Dr. Nance Katherine Dicciani is currently the Founder and CEO of RTM Vital Signs, LLC. From 2001 until 2008, Dr. Dicciani was the President & CEO of $5B+ Honeywell Specialty Materials. She joined Honeywell from Rohm & Haas where she held the position of Business Group Executive and Director, European Region, Middle East and Africa. Prior to Rohm and Haas, Dicciani held various research, business development, and business management positions at Air Products and Chemicals. Innovation and commercialization of new products and applications have been central to the revenue growth, profitability increases and business expansion which have been the hallmarks of Nance’s career.
Nance has served on the corporate Boards of Directors of Halliburton, LyondellBasell, Linde PLC, and AgroFresh Solutions, Rockwood Inc and PP&L. In 2006, she was appointed by President George W. Bush to the President’s Council of Advisors on Science and Technology. She has also served as Advisory Board Chair of the Gupta Governance Institute of Drexel University, is a former Trustee of Villanova University and has held numerous leadership positions in professional and industry organizations. Nance holds a BS from Villanova, an MS from the University of Virginia, and a PhD from the University of Pennsylvania, all in Chemical Engineering and an MBA from the Wharton School. She was twice named to the Forbes list of “The World’s Most Powerful Women” and is an instrument rated pilot. Dicciani has been elected as a member of the National Academy of Engineering Class of 2025. Dicciani resides in Lower Gwynedd, PA.
Denise Devine
Co-Founder, CAO, CFO
Denise L. Devine, CPA, MBA, MST, is Co-Founder, CAO, and CFO of RTM Vital Signs, LLC. She has over twenty-five years of leadership experience in general management, operations, and finance. Her experience spans entrepreneurial start-ups to Fortune 100 corporations, international consulting firms, manufacturing operations, and software companies. Ms. Devine is founder of three companies. As Founder and Chief Executive Officer of Nutripharm, Inc., Ms. Devine led the development of a technology platform that generated a portfolio of patents creating innovations in the food, beverage, pharmaceutical, nutraceutical and OTC Pharmaceutical space. Ms. Devine has executed strategic alliances and licenses with pharmaceutical and food companies and completed a CRADA with USDA.
Ms. Devine’s prior business experience includes executive positions at Campbell Soup Company, where she was responsible for executing close to a billion in financings, investment strategy, and structuring and negotiating various capital markets transactions, acquisitions, divestitures, and joint ventures in the food industry; CFO of Energy Solutions International, a global software company serving the oil and gas industry; and Arthur Andersen & Co., where she served as a member of the firm’s closely-held national business team.
Ms. Devine has served on the Boards of Villanova University, Lourde Health System, Fulton Financial Corporation, Cubic Corporation, Agrofresh, Inc., Select Quote and Innovative Solutions and Support. She is Vice Chair of the Board of Ben Franklin Technology Partners and has served as an “Entrepreneur in Residence” at The Wharton School of The University of Pennsylvania.
Ms. Devine, a CPA, received an MBA from the Wharton School of the University of Pennsylvania, an MS in Taxation from Villanova University and a BS in Accounting from Villanova University.
Dr. Jeff Joseph
Co-Founder
Chairman of Scientific/Clinical Advisory Boards
Dr. Jeffrey I. Joseph, D.O., is Co-Founder and Chairman of the Scientific/Clinical Advisory Boards of RTM Vital Signs, LLC. Dr. Joseph has over thirty years of experience as a clinical anesthesiologist, researcher, and innovator of medical device technology. Dr. Joseph is Professor of Anesthesiology and Vice-Chairman of and Director of Research for the Department of Anesthesiology at the Sidney Kimmel Medical College of Thomas Jefferson University. Dr. Joseph is also Director of the Jefferson Artificial Pancreas Center and Associate Director of the Anesthesiology Program for Translational Research. In addition, Dr. Joseph is an Adjunct Professor of Biomedical Engineering at Drexel University.
Dr. Joseph is both an inventor and experienced entrepreneur. He is a named inventor on numerous patents related to implantable medical devices, biomaterials, vital sign monitoring, and drug delivery systems. Dr. Joseph is a Co-Founder of Animas Corporation, a medical device company that developed a long-term implantable glucose monitoring system and insulin pump leading to a closed-loop artificial pancreas system to help patients manage their diabetes. Animas had a successful Initial Public Offering in 2004 (Nasdaq: PUMP) and was acquired by Johnson & Johnson in 2005. Dr. Joseph was a Co-Founder and Chairman of the Scientific/Clinical Advisory Boards of Capillary Biomedical, Inc. which was sold in 2024. Dr. Joseph has a BS in Biology from Dickinson College and a DO from the Philadelphia College of Osteopathic Medicine.